The FDA's Orthopaedic and Rehabilitation Devices panel is scheduled to meet Nov. 4 to evaluate Zimmer's request for postmarketing approval for its Dynesys dynamic spinal stabilization device, which is used as a fusion surgery adjunct. Zimmer is one of the orthopedic device firms asked by the agency to conduct postmarket studies of the devices.

Related Summaries